Anhui Rubiox-vision Biotechnology Company

Country/Region: China

Main Products: Peptides, Nucleic Acids, Protein, Antibodies And Scientific Research, Peptides

Company Introduction
With years of affluent industry expertise and experience, Anhui Rubiox-vision Biotechnology Company Corporation Limited Liability Company takes pride in providing an extensive range of D Protein along with peptides, nucleic acids, protein,antibodies and scientific research. Our D Protein is quality assured and comply with international industry standards which is very important to us owing to the international export market share including Australia,Canada,Germany,India,United Kingdom. Buyers can expect superior grade pieces, reliability and admirable specifications in price, having no match. It helped us expand our consumer base and in no time we reached Approx 5 Million US Dollar worth of annual revenue.The high-tech storage facility and an ultramodern inventory management system launched with initial business capital of Below US$1 Million and sufficient production capacity caters to US$2.5 Million - US$5 Million of export value, keeping the consumer reliability in check. Anhui Rubiox-vision Biotechnology Company is a located in Hefei, Anhui, China operating under Third Party, but boast a vast distribution network, it has always been easy for us to deliver bulk and retail orders. Being a reputable Manufacturer and Exporter of [keywords] since 2009, we have been successfully delivering to customers holding 11 Years of export history.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2009, 2009

Legal Status: Third Party

Ownership: Corporation Limited Liability Company

Employees: 501 - 1000 People

Factory Size: 5, 000-10, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: ISO13485

Contact Information

Contact Person: jinyun liu

Designation: Marketing

Department: Managing director

Telephone: 0086-13739293202

Business Information

Main Markets: Canada (28%) India (25%) Germany (22%) Australia (19%) United Kingdom (19%)

Export Focus: Australia, Canada, Germany, India, United Kingdom

Contract Services: Buyer Label Offered

Trade & Financial Information

Annual Revenue: Approx 5 Million US Dollar

Registered Capital: Below US$1 Million

Export Percentage: 81% - 90%

Payment Terms: Bank wire (T/T), Doc Against Acceptance (D/A), PayPal, Cash

Product Showcase
peptides
nucleic acids
protein
antibodies and scientific research
peptides

CL-Link > Health & Medicines in China Health Care Supplement in China D Protein in China